Previous 10 | Next 10 |
Amylyx Pharmaceuticals ( NASDAQ: AMLX ) on Friday said its Albrioza treatment for neurodegenerative disease amyotrophic lateral sclerosis (ALS) was now commercially available for use by patients in Canada. AMLX's Albrioza, also known as AMX0035, is an oral combination ther...
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) (“Amylyx” or the “Company”) today announced that ALBRIOZA™ (sodium phenylbutyrate and ursodoxicoltaurine) is now commercially available in Canada for people living with amyotrophic lateral sclerosis (ALS). AL...
Amylyx Pharmaceuticals ( NASDAQ: AMLX ) has e ntered into a two-year agreement with the Sunnybrook Research Institute to develop drug candidates for neurodegenerative diseases. Specifically, the companies will work to identify candidates that inhibit the proteins ...
Project to support identification of Bax and Bak inhibitor therapeutic candidates with the potential to treat ALS and other neurodegenerative diseases Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) (“Amylyx” or the “Company”) today announced a two-ye...
Gainers: Inspira Technologies Oxy ( IINN ) +98% . Cano Health CANO +18% . Veru VERU +16% . Amylyx Pharmaceuticals ( AMLX ) +13% . Equillium ( EQ ) +12% . Losers: Applied Molecular Transport AMTI -26% . HTG Molecular D...
Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the “Company”) today announced a poster on the ongoing international Phase 3 PHOENIX trial (study A35-004, NCT05021536 ) of AMX0035 (sodium phenylbutyrate [PB] and taurursodiol [TURSO; also known as...
Amylyx Pharmaceuticals (NASDAQ: AMLX) , a clinical-stage biopharma , is off to a good start this week. Shares of the small-cap biotech are up by a healthy 12%, on above-average volume, as of 11:54 a.m. ET Tuesday morning. What's sparking this double-digit rally? Amylyx's sha...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: cortex-film / Shutterstock.com Novavax (NASDAQ: NVAX ) stock is taking off on Tuesday after the vaccine company got approval for the expanded use of its Covid-19 vaccine in Europe . This has the Europ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips After some apparent hesitation, the Food and Drug Administration (FDA) has agreed to consider — or more accurately, reconsider — Amylyx Pharmaceuticals’ (NASDAQ: AMLX ) application for an amyotr...
Gainers: Alpha Tau Medical ( DRTS ) +42% . Precigen ( PGEN ) +20% . Amylyx Pharmaceuticals ( AMLX ) +18% . bluebird bio ( BLUE ) +13% . Talaris Therapeutics ( TALS ) +11% . Losers: Revelation Biosciences ( REVB ...
News, Short Squeeze, Breakout and More Instantly...
Amylyx Pharmaceuticals Inc. Company Name:
AMLX Stock Symbol:
NASDAQ Market:
Amylyx Pharmaceuticals Inc. Website:
- Avexitide is a novel, first-in-class GLP-1 receptor antagonist with the potential to treat hyperinsulinemic hypoglycemia - FDA Breakthrough Therapy Designation granted for avexitide for post-bariatric hypoglycemia (PBH) and congenital hyperinsulinism - Acquisition builds on Am...
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) (“Amylyx” or the “Company”) today announced that Amylyx’ management team will host a conference call and webcast tomorrow, Wednesday, July 10, 2024, at 8:00 a.m. ET to discuss the acquisition of avexitide from Eiger ...
Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the “Company”) today announced that management will participate in a fireside chat presentation at the Goldman Sachs 45th Annual Global Healthcare Conference. The conference is being conducted in-person in Miam...